Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Carr

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The Lancet Regional Health. Europe|June 26, 2023
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study, Edward P K Parker, Elsie M F Horne, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Influenza and Other Respiratory Viruses|August 14, 2025
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus MicroneutralisationLorin Adams, Phoebe Stevenson-Leggett, Jia Le Lee, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Clinical Kidney Journal|November 2, 2023
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databasesBang Zheng, Jacqueline Campbell, Edward J Carr, et al.
Nature Aging|April 28, 2023
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homesGokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Lancet (London, England)|August 15, 2021
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Lancet (London, England)|January 22, 2022
Three-dose vaccination elicits neutralising antibodies against omicronMary Wu, Emma C Wall, Edward J Carr, et al.
Nature Immunology|May 22, 2023
Spatial dysregulation of T follicular helper cells impairs vaccine responses in agingAlyssa Silva-Cayetano, Sigrid Fra-Bido, Philippe A Robert, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The Lancet Regional Health. Europe|June 26, 2023
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study, Edward P K Parker, Elsie M F Horne, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Influenza and Other Respiratory Viruses|August 14, 2025
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus MicroneutralisationLorin Adams, Phoebe Stevenson-Leggett, Jia Le Lee, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Clinical Kidney Journal|November 2, 2023
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databasesBang Zheng, Jacqueline Campbell, Edward J Carr, et al.
Nature Aging|April 28, 2023
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homesGokhan Tut, Tara Lancaster, Maria Krutikov, et al.
Lancet (London, England)|August 15, 2021
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Lancet (London, England)|January 22, 2022
Three-dose vaccination elicits neutralising antibodies against omicronMary Wu, Emma C Wall, Edward J Carr, et al.
Nature Immunology|May 22, 2023
Spatial dysregulation of T follicular helper cells impairs vaccine responses in agingAlyssa Silva-Cayetano, Sigrid Fra-Bido, Philippe A Robert, et al.
Pageof 6